pioglitazone has been researched along with Intertrochanteric Fractures in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colhoun, HM | 1 |
Livingstone, SJ | 1 |
Looker, HC | 1 |
Morris, AD | 1 |
Wild, SH | 1 |
Lindsay, RS | 1 |
Reed, C | 1 |
Donnan, PT | 1 |
Guthrie, B | 1 |
Leese, GP | 1 |
McKnight, J | 1 |
Pearson, DW | 1 |
Pearson, E | 1 |
Petrie, JR | 1 |
Philip, S | 1 |
Sattar, N | 1 |
Sullivan, FM | 1 |
McKeigue, P | 1 |
1 other study available for pioglitazone and Intertrochanteric Fractures
Article | Year |
---|---|
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs.
Topics: Age Distribution; Aged; Databases, Factual; Diabetes Mellitus, Type 2; Drug Prescriptions; Female; F | 2012 |